212 related articles for article (PubMed ID: 36927960)
1. RIP140 deficiency enhances cardiac fuel metabolism and protects mice from heart failure.
Yamamoto T; Maurya SK; Pruzinsky E; Batmanov K; Xiao Y; Sulon SM; Sakamoto T; Wang Y; Lai L; McDaid KS; Shewale SV; Leone TC; Koves TR; Muoio DM; Dierickx P; Lazar MA; Lewandowski ED; Kelly DP
J Clin Invest; 2023 May; 133(9):. PubMed ID: 36927960
[TBL] [Abstract][Full Text] [Related]
2. Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes.
You J; Yue Z; Chen S; Chen Y; Lu X; Zhang X; Shen P; Li J; Han Q; Li Z; Liu P
Acta Physiol (Oxf); 2017 May; 220(1):58-71. PubMed ID: 27614093
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function.
Fritah A; Steel JH; Nichol D; Parker N; Williams S; Price A; Strauss L; Ryder TA; Mobberley MA; Poutanen M; Parker M; White R
Cardiovasc Res; 2010 Jun; 86(3):443-51. PubMed ID: 20083575
[TBL] [Abstract][Full Text] [Related]
4. Plin5 deficiency exacerbates pressure overload-induced cardiac hypertrophy and heart failure by enhancing myocardial fatty acid oxidation and oxidative stress.
Wang C; Yuan Y; Wu J; Zhao Y; Gao X; Chen Y; Sun C; Xiao L; Zheng P; Hu P; Li Z; Wang Z; Ye J; Zhang L
Free Radic Biol Med; 2019 Sep; 141():372-382. PubMed ID: 31291602
[TBL] [Abstract][Full Text] [Related]
5. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
[TBL] [Abstract][Full Text] [Related]
6. Short-term but not long-term high fat diet feeding protects against pressure overload-induced heart failure through activation of mitophagy.
Tan Y; Li M; Wu G; Lou J; Feng M; Xu J; Zhou J; Zhang P; Yang H; Dong L; Li J; Zhang X; Gao F
Life Sci; 2021 May; 272():119242. PubMed ID: 33607155
[TBL] [Abstract][Full Text] [Related]
7. Receptor-interacting protein 140 overexpression impairs cardiac mitochondrial function and accelerates the transition to heart failure in chronically infarcted rats.
Chen Y; Chen S; Yue Z; Zhang Y; Zhou C; Cao W; Chen X; Zhang L; Liu P
Transl Res; 2017 Feb; 180():91-102.e1. PubMed ID: 27639592
[TBL] [Abstract][Full Text] [Related]
8. Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.
Xu W; Billon C; Li H; Wilderman A; Qi L; Graves A; Rideb JRDC; Zhao Y; Hayes M; Yu K; Losby M; Hampton CS; Adeyemi CM; Hong SJ; Nasiotis E; Fu C; Oh TG; Fan W; Downes M; Welch RD; Evans RM; Milosavljevic A; Walker JK; Jensen BC; Pei L; Burris T; Zhang L
Circulation; 2024 Jan; 149(3):227-250. PubMed ID: 37961903
[TBL] [Abstract][Full Text] [Related]
9. Roles of transcriptional corepressor RIP140 and coactivator PGC-1α in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes.
Chen Y; Wang Y; Chen J; Chen X; Cao W; Chen S; Xu S; Huang H; Liu P
Mol Cell Endocrinol; 2012 Oct; 362(1-2):11-8. PubMed ID: 22503866
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
[TBL] [Abstract][Full Text] [Related]
11. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
[TBL] [Abstract][Full Text] [Related]
12. Crucial Role of Mammalian Glutaredoxin 3 in Cardiac Energy Metabolism in Diet-induced Obese Mice Revealed by Transcriptome Analysis.
Cheng N; Mo Q; Donelson J; Wang L; Breton G; Rodney GG; Wang J; Hirschi KD; Wehrens XHT; Nakata PA
Int J Biol Sci; 2021; 17(11):2871-2883. PubMed ID: 34345213
[TBL] [Abstract][Full Text] [Related]
13. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
[TBL] [Abstract][Full Text] [Related]
14. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes.
Powelka AM; Seth A; Virbasius JV; Kiskinis E; Nicoloro SM; Guilherme A; Tang X; Straubhaar J; Cherniack AD; Parker MG; Czech MP
J Clin Invest; 2006 Jan; 116(1):125-36. PubMed ID: 16374519
[TBL] [Abstract][Full Text] [Related]
15. Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion.
Choi YS; de Mattos AB; Shao D; Li T; Nabben M; Kim M; Wang W; Tian R; Kolwicz SC
J Mol Cell Cardiol; 2016 Nov; 100():64-71. PubMed ID: 27693463
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte-specific loss of RNA polymerase II subunit 5-mediating protein causes myocardial dysfunction and heart failure.
Zhang J; Sheng J; Dong L; Xu Y; Yu L; Liu Y; Huang X; Wan S; Lan HY; Wang H
Cardiovasc Res; 2019 Sep; 115(11):1617-1628. PubMed ID: 30590389
[TBL] [Abstract][Full Text] [Related]
17. The energy substrate switch during development of heart failure: gene regulatory mechanisms (Review).
Sack MN; Kelly DP
Int J Mol Med; 1998 Jan; 1(1):17-24. PubMed ID: 9852194
[TBL] [Abstract][Full Text] [Related]
18. Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth.
Lehman JJ; Kelly DP
Heart Fail Rev; 2002 Apr; 7(2):175-85. PubMed ID: 11988641
[TBL] [Abstract][Full Text] [Related]
19. Enhancing fatty acid utilization ameliorates mitochondrial fragmentation and cardiac dysfunction via rebalancing optic atrophy 1 processing in the failing heart.
Guo Y; Wang Z; Qin X; Xu J; Hou Z; Yang H; Mao X; Xing W; Li X; Zhang X; Gao F
Cardiovasc Res; 2018 Jun; 114(7):979-991. PubMed ID: 29490017
[TBL] [Abstract][Full Text] [Related]
20. Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure.
Tsuda M; Fukushima A; Matsumoto J; Takada S; Kakutani N; Nambu H; Yamanashi K; Furihata T; Yokota T; Okita K; Kinugawa S; Anzai T
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):844-859. PubMed ID: 30168279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
